We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
+3.41%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
AUM
$1.76B
AUM Growth
-$218M
Cap. Flow
-$265M
Cap. Flow %
-15.02%
Top 10 Hldgs %
22.75%
Holding
203
New
31
Increased
55
Reduced
62
Closed
55

Top Buys

Rank Stock Value
1
RNG icon
RingCentral
RNG
+$36.8M
2
ACHC icon
Acadia Healthcare
ACHC
+$30.7M
3
BILL icon
BILL Holdings
BILL
+$20.8M
4
OMC icon
Omnicom Group
OMC
+$15.9M
5
EQX icon
Equinox Gold
EQX
+$14.9M

Top Sells

Rank Stock Value
1
DNB
Dun & Bradstreet
DNB
+$33.6M
2
SLB icon
SLB Ltd
SLB
+$23.7M
3
MTCH icon
Match Group
MTCH
+$22.9M
4
MUR icon
Murphy Oil
MUR
+$19.4M
5
LYFT icon
Lyft
LYFT
+$18.8M

Sector Composition

Rank Sector Weight
1 Technology 25.6%
2 Consumer Discretionary 17.8%
3 Healthcare 16.38%
4 Industrials 9.22%
5 Materials 9.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FLYW icon
76
Flywire
FLYW
$2.16B
$7.4M 0.42%
632,576
-882,039
-58% -$8.98M
GEHC icon
77
GE HealthCare
GEHC
$32.4B
$7.16M 0.41%
+96,697
New +$6.73M
AVDL
78
DELISTED
Avadel Pharmaceuticals
AVDL
$7.11M 0.4%
802,994
+574,968
+252% +$5.05M
CXT icon
79
Crane NXT
CXT
$3.07B
$6.95M 0.39%
128,889
+3,262
+3% +$166K
IART icon
80
Integra LifeSciences
IART
$1.34B
$6.78M 0.38%
+552,214
New +$8.02M
ZD icon
81
Ziff Davis
ZD
$1.98B
$6.65M 0.38%
219,605
+50,543
+30% +$1.62M
NOMD icon
82
Nomad Foods
NOMD
$1.68B
$6.63M 0.38%
389,964
+179,277
+85% +$3.29M
CXW icon
83
CoreCivic
CXW
$3.19B
$6.57M 0.37%
311,597
-595,793
-66% -$12.8M
OVV icon
84
Ovintiv
OVV
$16.4B
$6.56M 0.37%
172,468
-467,131
-73% -$17.1M
EGHT icon
85
8x8 Inc
EGHT
$332M
$6.53M 0.37%
3,329,653
-505,711
-13% -$893K
TROX icon
86
Tronox
TROX
$1.04B
$6.5M 0.37%
1,281,423
+830,541
+184% +$4.52M
BDC icon
87
Belden
BDC
$5.19B
$6.25M 0.35%
+53,944
New +$5.67M
VZ icon
88
Verizon
VZ
$196B
$6.14M 0.35%
141,805
-368,598
-72% -$16M
ALGN icon
89
Align Technology
ALGN
$12.3B
$6.09M 0.35%
32,187
+9,681
+43% +$1.71M
FFWM
90
DELISTED
First Foundation Inc
FFWM
$6.07M 0.34%
1,190,200
+281,227
+31% +$1.44M
VC icon
91
Visteon
VC
$2.78B
$5.87M 0.33%
62,941
+12,082
+24% +$994K
MHK icon
92
Mohawk Industries
MHK
$9.22B
$5.82M 0.33%
55,485
-538
-1% -$56.1K
OEC icon
93
Orion
OEC
$409M
$5.76M 0.33%
549,358
+307,651
+127% +$3.48M
GETY icon
94
Getty Images
GETY
$183M
$5.76M 0.33%
3,466,932
+781,435
+29% +$1.38M
B
95
Barrick Mining
B
$73.2B
$5.72M 0.32%
274,832
-38,683
-12% -$756K
DCH
96
Dauch Corp
DCH
$1.51B
$5.55M 0.31%
+1,359,307
New +$5.48M
SPT icon
97
Sprout Social
SPT
$621M
$5.48M 0.31%
261,926
+123,935
+90% +$2.63M
PRAA icon
98
PRA Group
PRAA
$755M
$5.35M 0.3%
+362,413
New +$5.77M
CRM icon
99
Salesforce
CRM
$158B
$5.19M 0.29%
+19,021
New +$5.09M
UHS icon
100
Universal Health Services
UHS
$10.5B
$4.84M 0.27%
+26,731
New +$4.82M

Similar funds

Invenomic Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, Invenomic Capital Management held 203 positions worth $1.76B, down 11% from $1.98B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Invenomic Capital Management withdrew a net $265M in Q2 2025, closing 55 positions and reducing 62 holdings. Its most notable exit was Dun & Bradstreet, an estimated $33.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Invenomic Capital Management opened a new position in RingCentral worth $40.5M.

  • Invenomic Capital Management's largest Q2 2025 buy was RingCentral: 1,427,359 shares worth $40.5M.
  • Invenomic Capital Management added most to Acadia Healthcare in Q2 2025, an estimated $30.7M increase.
  • Invenomic Capital Management's biggest Q2 2025 reduction was Match Group, cutting an estimated $22.9M.
  • Invenomic Capital Management fully exited Dun & Bradstreet in Q2 2025, selling an estimated $33.6M.
  • Invenomic Capital Management's ten largest holdings make up 23% of its $1.76B portfolio in Q2 2025.
  • Invenomic Capital Management opened 31 new positions and closed 55 in Q2 2025.
  • Invenomic Capital Management's portfolio value fell 11% quarter-over-quarter to $1.76B.

Based on Invenomic Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.